Genzyme launches troponin-I range:
This article was originally published in Clinica
Genzyme has launched a range of four troponin-I monoclonal antibodies and a cardiac troponin-I antigen. According to the US company, cross reactivity with skeletal muscle is 0-7%, depending on the clone. The markers are manufactured by Genzyme's California-based subsidiary Medix.